Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Human Vaccines & Immunotherapeutics

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/hv.18468PMID 22426370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nucleotide Sequence Requirements at the 5′ End of the Influenza A Virus M RNA Segment for Efficient Virus Replication

  2009cited by this paper
• Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1).

  2008influential reference
• Mutational Analysis of cis-Acting RNA Signals in Segment 7 of Influenza A Virus

  2008cited by this paper
• Enhanced growth of seed viruses for H5N1 influenza vaccines.

  2007cited by this paper
• Highly Conserved Regions of Influenza A Virus Polymerase Gene Segments Are Critical for Efficient Viral RNA Packaging

  2007cited by this paper
• Specific Residues of the Influenza A Virus Hemagglutinin Viral RNA Are Important for Efficient Packaging into Budding Virions

  2007cited by this paper
• Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

  2007cited by this paper
• Rescue of influenza A virus from recombinant DNA.

  2007cited by this paper
• Mutational Analyses of Packaging Signals in Influenza Virus PA, PB1, and PB2 Genomic RNA Segments

  2007cited by this paper
• Rolling circle amplification-RACE: a method for simultaneous isolation of 5' and 3' cDNA ends from amplified cDNA templates.

  2006cited by this paper
• Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

  2006cited by this paper
• The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

  2006cited by this paper
• Contributions of Two Nuclear Localization Signals of Influenza A Virus Nucleoprotein to Viral Replication

  2006cited by this paper
• cis-Acting Packaging Signals in the Influenza Virus PB1, PB2, and PA Genomic RNA Segments

  2005cited by this paper
• Probable person-to-person transmission of avian influenza A (H5N1).

  2005cited by this paper
• Evolution of H5N1 Avian Influenza Viruses in Asia

  2005cited by this paper
• Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

  2005cited by this paper
• Importance of both the Coding and the Segment-Specific Noncoding Regions of the Influenza A Virus NS Segment for Its Efficient Incorporation into Virions

  2005cited by this paper
• Exploitation of Nucleic Acid Packaging Signals To Generate a Novel Influenza Virus-Based Vector Stably Expressing Two Foreign Genes

  2003cited by this paper
• Selective incorporation of influenza virus RNA segments into virions

  2003cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

  2000cited by this paper
• Generation of influenza A viruses entirely from cloned cDNAs.

  1999cited by this paper
• Orthomyxoviridae: The Viruses and Their Replication.

  1996cited by this paper
• Mechanism of attenuation of a chimeric influenza A/B transfectant virus

  1992cited by this paper
• An influenza A virus containing influenza B virus 5' and 3' noncoding regions on the neuraminidase gene is attenuated in mice.

  1991cited by this paper
• Genetic applications of an inverse polymerase chain reaction.

  1988cited by this paper
• Replication of the influenza virus genome.

  1982cited by this paper
• Assembly of lipid-containing viruses.

  1974cited by this paper
• Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase

  1968cited by this paper

• Genetic Optimization of Early 2009 Pandemic H1N1 Vaccine Strains for Improved Replication in Embryonated Chicken Eggs

  2025cites this paper
• Enhanced hemagglutination titers of avian influenza A (H5N1) viruses grown in eggs by replacing the noncoding regions of neuraminidase

  2025cites this paper
• A decavalent composite mRNA vaccine against both influenza and COVID-19

  2024cites this paper
• Influenza Virus Carrying a Codon-Reprogrammed Neuraminidase Gene as a Strategy for Live Attenuated Vaccine

  2023influential citation
• Identification of the properties of H5 influenza vaccine viruses with high hemagglutinin yields

  2023cites this paper
• Segment 2 from influenza A(H1N1) 2009 pandemic viruses confers temperature-sensitive haemagglutinin yield on candidate vaccine virus growth in eggs that can be epistatically complemented by PB2 701D.

  2019cites this paper
• Segment 2 from influenza A(H1N1) 2009 1 pandemic viruses confers temperature sensitive 2 HA yield on candidate vaccine virus growth in 3 eggs that can be epistatically complemented by 4 PB2 701D 5

  2019cites this paper
• Segment 2 from influenza A(H1N1)pdm09 viruses confers temperature sensitive HA yield on candidate vaccine virus growth in eggs that is complemented by PB2 701D

  2019cites this paper
• Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses

  2018cites this paper
• Patient-derived avian influenza A (H5N6) virus is highly pathogenic in mice but can be effectively treated by anti-influenza polyclonal antibodies

  2018cites this paper
• Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs.

  2017cites this paper
• Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus.

  2017cites this paper
• NS gene of influenza virus A/swine/IA/15/30 increases the replication rate of A/Puerto Rico/8/34 in MDCK and Vero cells

  2015cites this paper
• Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.

  2015cites this paper
• Gene function analysis in osteosarcoma based on microarray gene expression profiling.

  2015cites this paper
• trengthening the influenza vaccine virus selection and development rocess eport of the 3 rd WHO Informal Consultation for Improving Influenza accine Virus Selection held at WHO headquarters , Geneva , witzerland , 1 – 3 April 2014 illiam

  2015cites this paper
• Error-prone pcr-based mutagenesis strategy for rapidly generating high-yield influenza vaccine candidates.

  2015cites this paper
• Development of high-yield influenza A virus vaccine viruses

  2015cites this paper
• Chimeric neuraminidase and mutant PB1 gene constellation improves growth and yield of H5N1 vaccine candidate virus.

  2015cites this paper
• Improving influenza virus backbones by including terminal regions of MDCK-adapted strains on hemagglutinin and neuraminidase gene segments.

  2013cites this paper